Zhejiang Medicine Co., Ltd. provided earnings guidance for the first quarter of 2018. For the quarter, the company predicts an increase of between RMB 435,990,000 and RMB 525,990,000 in the net profit belonging to shareholders of listed company in the first quarter of 2018, with an increase of between 1,815.81% and 2,190.65% compared with the same period of the year before (RMB 24,010,700). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by between RMB 435,400,000 and RMB 525,400,000, with an increase of between 2,220.95% and 2,680.04% compared with the same period of the year before (RMB 19,604,000).